[1]
Saseedharan, S., Aneja, P., Chowti, A., Debnath, K., Mehta, K.D. and Sonone, P. 2021. Efficacy and safety of intravenous and/or oral levonadifloxacin in the management of secondary bacterial pulmonary infections in COVID-19 patients: findings of a retrospective, real-world, multi-center study. International Journal of Research in Medical Sciences. 9, 10 (Sep. 2021), 2933–2939. DOI:https://doi.org/10.18203/2320-6012.ijrms20213685.